Advanced Search
Contact | Corporate | Help

Bevacizumab With Hormonal and Radiotherapy for High-Risk Prostate Cancer

Sponsors:
  • Benaroya Research Institute
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Prostate Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Male
Names:
  • Drug: bevacizumab, bicalutamide and goserelin
  • Procedure: intensity modulated radiation therapy (IMRT)
Enrollment:
18

Additional information about NCT00349557.


SourceSolution © 2008-2012